September 16, 2020
RICHLAND, WASHINGTON – September 16, 2020 – Isoray, Inc. (NYSE American: ISR), a medical technology company and ...
September 10, 2020
Conference Call is Thursday, September 17, 2020, at 4:30 p.m. ET/1:30 p.m. PT
RICHLAND, WASHINGTON – September ...
June 17, 2020
Trial Will Evaluate Use of Pembrolizumab, Known as Keytruda®*, With Cesium-131 and Surgical Resection RICHLAND, ...
June 2, 2020
RICHLAND, WASHINGTON – June 2, 2020 – Isoray, Inc. (NYSE American: ISR) today announced that the results of a new ...
May 12, 2020
RICHLAND, WASHINGTON – May 12, 2020 – Isoray, Inc. (NYSE American: ISR) today announced that the Centers for ...
May 12, 2020
Record Revenue and Gross Profit
Revenue Increased 50% Year-Over-Year
RICHLAND, WASHINGTON – May 12, 2020 – ...
May 4, 2020
Conference Call is May 12 at 4:30 p.m. ET/1:30 p.m. PT
RICHLAND, WASHINGTON – May 4, 2020 – Isoray, Inc. (NYSE ...
February 11, 2020
Revenue Increased 16% Year-Over-Year
Gross Profit Increased 45% Year-Over-Year
RICHLAND, WASHINGTON – February ...
February 5, 2020
Bundled Treatment Program Provides New Opportunities For
Treating Physicians and Patients Facing Limited ...
January 31, 2020
Conference Call is Tuesday, February 11, 2020 at 4:30 p.m. ET/1:30 p.m. PT
RICHLAND, WASHINGTON – January 31, ...
November 12, 2019
Record Revenue and Gross Profit
Revenue Increased 48% Year-Over-Year
RICHLAND, WASHINGTON – November 12, 2019 – ...
October 31, 2019
Conference Call is Tuesday, November 12, 2019 at 4:30 p.m. ET/1:30 p.m. PT
RICHLAND, WASHINGTON – October 31, ...
